Virus resistance to the CXCR4 inhibitor AMD070 develops slowly and does not induce a co-receptor switch

Kurt Vermeire; Sigrid Hatse; Katrien Princen; De Clercq Erik; Gary Calandra; Renato T. Skerlj; Gary Bridger; Dominique Schols

Related publications

Article2004

Anti-HIV activity profile of a novel CCR5 inhibitor, AMD887, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article1998

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella, Dominique Schols, Steven Lin, José A. Esté, Kirsten Nagashima, Paul J. Maddon, Graham P. Allaway, Thomas P. Sakmar, Geoffrey Henson, De Clercq Erik, John P. Moore

Article2004

In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article2005

Resistance profile of human immunodeficiency virus to CADA, a novel HIV inhibitor that targets the cellular CD4 receptor

Kurt Vermeire, Kristel Van Laethem, Anne‐Mieke Vandamme, Thomas W. Bell, De Clercq Erik, Dominique Schols

Article2008

Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation

Stephanie Lewis, Niranjan B. Butchi, Mohammed Khaleduzzaman, Tim W. Morgan, Min Du, Susan S. Pourciau, David G. Baker, Akira Shizuo, Karin E. Peterson

Journal of NeuroVirology